What the endothelium does
The vascular endothelium is the single-cell layer lining all blood vessels. It produces vasodilators (nitric oxide), regulates inflammation, controls coagulation, and acts as a barrier between blood and vessel wall. Endothelial dysfunction is the earliest measurable abnormality in cardiovascular disease, often present years before clinical events.
Low T endothelial effects
Men with low testosterone show:
- Reduced flow-mediated dilation (FMD), direct measure of endothelial function
- Reduced nitric oxide bioavailability
- Increased oxidative stress in vasculature
- Increased vascular inflammation markers
- Higher rates of erectile dysfunction (a vascular phenomenon)
TRT mechanisms on vasculature
- Increased nitric oxide synthase (eNOS) expression and activity
- Reduced reactive oxygen species (ROS) in vasculature
- Reduced inflammatory cytokine production in vessel wall
- Modulation of vascular smooth muscle
- Direct testosterone vasodilation in some studies
Nitric oxide pathway
Nitric oxide is the master vasodilator. Endothelial cells produce NO, which diffuses to smooth muscle, causes relaxation, and produces vasodilation. NO is the basis of erection, blood pressure regulation, and tissue perfusion. Testosterone supports the NO pathway through:
- Direct effects on eNOS expression
- Reduced oxidative inactivation of NO
- Indirect effects via metabolic improvement
Erectile function link
Erectile dysfunction is a vascular phenomenon. The penile vasculature is small and shows endothelial dysfunction earlier than larger vessels. ED is often the first sign of broader vascular dysfunction.
TRT often improves erectile function in men with low T, partly through libido and central effects, partly through restored vascular function. PDE5 inhibitors (sildenafil, tadalafil) work better when the underlying vascular system is healthier.
Cardiovascular implications
Restored vascular function on TRT contributes to:
- Modest blood pressure improvement
- Improved tissue perfusion
- Reduced cardiovascular event risk
- Better exercise capacity
- Improved cognitive function (cerebral perfusion)
The TRAVERSE trial's confirmation of cardiovascular safety reflects in part this vascular contribution.
The clinical insight: Erectile dysfunction is the canary in the cardiovascular coal mine. Improvement on TRT often signals broader vascular improvement. Conversely, ED unresponsive to lifestyle and hormone optimization warrants cardiovascular workup.
Bottom line
Testosterone supports vascular endothelial function through nitric oxide synthase, anti-inflammatory effects, and direct vasodilation. Low T contributes to endothelial dysfunction; TRT typically improves vascular markers. The vascular effects underlie cardiovascular, erectile, and broader perfusion benefits of treatment.